International Journal of Cell Biology and G. Lubec, “Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders,” Brain Research, vol. 967, no. 1-2, pp. 152–160, 2003. [75] J. Fang, T. Nakamura, D. H. Cho, Z. Gu, and S. A. Lipton, “S-nitrosylation of peroxiredoxin 2 promotes oxidative stress- induced neuronal cell death in Parkinson’s disease,” Proceed- ings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18742–18747, 2007. [76] M. C. Romero-Puertas, M. Laxa, A. Matte` et al., “S- nitrosylation of peroxiredoxin II E promotes peroxynitrite- mediated tyrosine nitration,” Plant Cell, vol. 19, no. 12, pp. 4120–4130, 2007. [77] B. P. Eckelman, G. S. Salvesen, and F. L. Scott, “Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family,” EMBO Reports, vol. 7, no. 10, pp. 988–994, 2006. [78] G. S. Salvesen and C. S. Duckett, “IAP proteins: blocking the road to death’s door,” Nature Reviews Molecular Cell Biology, vol. 3, no. 6, pp. 401–410, 2002. [79] P. Fuentes-Prior and G. S. Salvesen, “The protein structures that shape caspase activity, speciﬁcity, activation and inhibi- tion,” Biochemical Journal, vol. 384, no. 2, pp. 201–232, 2004. [80] M. MacFarlane, W. Merrison, S. B. Bratton, and G. M. Cohen, “Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro,” Journal of Biological Chemistry, vol. 277, no. 39, pp. 36611–36616, 2002. [81] A. J. Schile, M. Garc´ıa-Ferna´ndez, and H. Steller, “Regulation of apoptosis by XIAP ubiquitin-ligase activity,” Genes and Development, vol. 22, no. 16, pp. 2256–2266, 2008. [82] Y. Suzuki, Y. Nakabayashi, and R. Takahashi, “Ubiquitin- protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic eﬀect in Fas-induced cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8662–8667, 2001. [83] D. L. Vaux and J. Silke, “IAPs, RINGs and ubiquitylation,” Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 287– 297, 2005. [84] Y. Yang, S. Fang, J. P. Jensen, A. M. Weissman, and J. D. Ashwell, “Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli,” Science, vol. 288, no. 5467, pp. 874–877, 2000. [85] T. Nakamura, L. Wang, C. C. L. Wong et al., “Transnitro- sylation of XIAP regulates caspase-dependent neuronal cell death,” Molecular Cell, vol. 39, no. 2, pp. 184–195, 2010. [86] A. H. K. Tsang, Y. I. L. Lee, H. S. Ko et al., “S-nitrosylation of XIAP compromises neuronal survival in Parkinson’s disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4900–4905, 2009. [87] M. R. Hara, N. Agrawal, S. F. Kim et al., “S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding,” Nature Cell Biology, vol. 7, no. 7, pp. 665–674, 2005. [88] H. Q. Wang and R. Takahashi, “Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson’s disease,” Antioxidants and Redox Signaling, vol. 9, no. 5, pp. 553–561, 2007. [89] V. Bonifati, P. Rizzu, M. J. Van Baren et al., “Mutations in the DJ-1 gene associated with autosomal recessive early- onset parkinsonism,” Science, vol. 299, no. 5604, pp. 256–259, 2003. [90] A. Mitsumoto, Y. Nakagawa, A. Takeuchi, K. Okawa, A. Iwa- matsu, and Y. Takanezawa, “Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat,” Free Radical Research, vol. 35, no. 9 3, pp. 301–310, 2001. [91] T. Taira, Y. Saito, T. Niki, S. M. M. Iguchi-Ariga, K. Takahashi, and H. Ariga, “DJ-1 has a role in antioxidative stress to prevent cell death,” EMBO Reports, vol. 5, no. 2, pp. 213–218, 2004. [92] T. Yokota, K. Sugawara, K. Ito, R. Takahashi, H. Ariga, and H. Mizusawa, “Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition,” Biochemical and Biophysical Research Communications, vol. 312, no. 4, pp. 1342–1348, 2003. [93] M. Meulener, A. J. Whitworth, C. E. Armstrong-Gold et al., “Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson’s disease,” Current Biology, vol. 15, no. 17, pp. 1572–1577, 2005. [94] F. M. Menzies, S. C. Yenisetti, and K. T. Min, “Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress,” Current Biology, vol. 15, no. 17, pp. 1578– 1582, 2005. [95] Y. Yang, S. Gehrke, M. E. Haque et al., “Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 38, pp. 13670–13675, 2005. [96] J. Park, Y. K. Sung, G. H. Cha, B. L. Sung, S. Kim, and J. Chung, “Drosophila DJ-1 mutants show oxidative stress- sensitive locomotive dysfunction,” Gene, vol. 361, no. 1-2, pp. 133–139, 2005. [97] R. H. Kim, P. D. Smith, H. Aleyasin et al., “Hypersensitivity of DJ-1-deﬁcient mice to 1-methyl-4-phenyl-1,2,3,6- tetrahy- dropyrindine (MPTP) and oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 14, pp. 5215–5220, 2005. [98] G. Ito, H. Ariga, Y. Nakagawa, and T. Iwatsubo, “Roles of dis- tinct cysteine residues in S-nitrosylation and dimerization of DJ-1,” Biochemical and Biophysical Research Communications, vol. 339, no. 2, pp. 667–672, 2006. [99] D. Seth and J. S. Stamler, “The SNO-proteome: causation and classiﬁcations,” Current Opinion in Chemical Biology, vol. 15, no. 1, pp. 129–136, 2011.